Clinical trial

Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies

NCT00492466

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-03-01

PhasePHASE4

Study timeline

Study start (unknown)2003-03-01Date precision: month

Registry last updated2008-01-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-Remitting Multiple Sclerosisunresolved

Interventions

Interferon-beta-1aDRUG

methylprednisoloneDRUG · verified · RxNorm: methylprednisolone

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

TurkuFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00492466 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.